X-group (possible homology)

2007 Flavodoxin-like

Ligands and drugs

67,130
Member domains
15,563
with ligand contacts (≤ 4 Å)
23.2% of members
12,989
with DrugDomain annotations
19.3% of members
8,518
with a DrugBank compound
12.7% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

1,212
Proteins with classified ligands
17
Superclasses bound (of 23)
8.9
Superclasses per 20 proteins
broader than 77% of the 256 X-groups with enough proteins to compare (median 7.6)

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Mixed metal/non-metal compounds7425.12.95×q < 0.0001
Organic oxygen compounds335238.01.41×q < 0.0001
Homogeneous non-metal compounds321257.21.25×q < 0.0001
Organic acids and derivatives221184.91.20×q = 8.4e-3
Organosulfur compounds2524.61.02×q = 0.95
Nucleosides, nucleotides, and analogues304330.30.92×q = 0.13
Homogeneous metal compounds496586.60.85×q < 0.0001
Benzenoids7287.40.82×q = 0.14
Organic nitrogen compounds2938.10.76×q = 0.19
Organoheterocyclic compounds114183.90.62×q < 0.0001
Lipids and lipid-like molecules60133.10.45×q < 0.0001
Phenylpropanoids and polyketides1124.90.44×q = 5.9e-3
Hydrocarbons08.40q = 8.9e-4
Organophosphorus compounds10.42.47×not tested
Miscellaneous inorganic compounds10.91.12×not tested
Organometallic compounds11.70.59×not tested
Organohalogen compounds13.40.29×not tested
Alkaloids and derivatives14.10.24×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00141NAGN-Acetylglucosamine868
DB03247FMNFlavin mononucleotide538
DB03147FADFlavin adenine dinucleotide256
DB14128NADNadide227
DB00142GLUGlutamic acid180
DB02338NDPNADPH174
DB01992COACoenzyme A147
DB03461NAPNicotinamide adenine dinucleotide phosphate135
DB00171ATPATP127
DB02517DGLD-Glutamic Acid108
DB02379BGCBeta-D-Glucose97
DB03581G6QGlucose-6-Phosphate95
DB16833ADPAdenosine disphosphate86
DB00157NAINADH83
DB09459TLAL-tartaric acid81
DB00130GLNL-Glutamine78
DB02548S6PD-glucitol 6-phosphate73
DB04162INI5-Nitro-6-ribityl-amino-2,4(1H,3H)-pyrimidinedione70
DB18267HEMFerroheme66
DB02659CHDCholic Acid61

Most frequently bound compounds

PDB ligandNameDomains in contact
NAG2-acetamido-2-deoxy-beta-D-glucopyranose1,390
MGmetalMAGNESIUM ION1,139
CLCHLORIDE ION1,132
CAmetalCALCIUM ION830
SF4IRON/SULFUR CLUSTER778
ZNmetalZINC ION682
FMNFLAVIN MONONUCLEOTIDE561
ICSiron-sulfur-molybdenum cluster with interstitial carbon462
HCA3-HYDROXY-3-CARBOXY-ADIPIC ACID458
NAmetalSODIUM ION404
FEmetalFE (III) ION391
CLFFE(8)-S(7) CLUSTER382
MNmetalMANGANESE (II) ION329
FADFLAVIN-ADENINE DINUCLEOTIDE278
NDPNADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE262
NADNICOTINAMIDE-ADENINE-DINUCLEOTIDE258
B12COBALAMIN205
BEFBERYLLIUM TRIFLUORIDE ION158
KmetalPOTASSIUM ION152
COACOENZYME A148